Core Viewpoint - Varonis Systems, Inc. has faced significant financial challenges, including a substantial decline in subscription revenues, leading to a sharp drop in stock price and prompting an investigation into potential violations of federal securities laws [2][3]. Financial Performance - On October 28, 2025, Varonis reported third-quarter financial results that missed consensus estimates, with a 63.9% year-over-year decline in term license subscription revenues [2]. - The company announced a reduction in its full-year Annual Recurring Revenue (ARR) guidance due to underperformance in its on-premises subscription business, which is identified as a drag on total company ARR growth [2]. Stock Market Reaction - Following the announcement of poor financial results, Varonis' stock price plummeted by $30.66 per share, or 48.67%, closing at $32.34 per share on October 29, 2025 [2]. Legal Investigation - Kessler Topaz Meltzer & Check, LLP is investigating potential violations of federal securities laws on behalf of Varonis investors, indicating possible legal repercussions for the company [1][3].

Core Viewpoint - The James Hardie Industries plc is facing a class action lawsuit due to allegations of misleading investors regarding the performance of its North America Fiber Cement segment, which reportedly experienced significant inventory destocking and a subsequent decline in sales [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit is titled "Laborers' District Council and Contractors' Pension Fund of Ohio v. James Hardie Industries plc" and is filed in the Northern District of Illinois [1]. - Investors who purchased James Hardie common stock between May 20, 2025, and August 18, 2025, can seek appointment as lead plaintiff until December 23, 2025 [1][5]. - The lawsuit alleges that James Hardie and its executives violated the Securities Exchange Act of 1934 by making false statements about the strength of their business segment [1][3]. Group 2: Allegations Against James Hardie - The lawsuit claims that despite early signs of inventory destocking in April and May 2025, James Hardie continued to assure investors of strong performance, misleading them about actual sales conditions [3]. - On August 19, 2025, James Hardie disclosed a 12% decline in sales for the North America Fiber Cement segment, which led to a stock price drop of over 34% [4]. Group 3: Legal Process and Firm Background - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased James Hardie common stock during the class period to seek lead plaintiff status, which involves directing the lawsuit on behalf of all class members [5]. - Robbins Geller Rudman & Dowd LLP, the law firm representing the investors, is recognized as a leading firm in securities fraud litigation, having recovered over $2.5 billion for investors in 2024 alone [6].

PHILADELPHIA, Dec. 2, 2025 /PRNewswire/ -- National plaintiffs' law firm Berger Montague PC announces that a class action lawsuit has been filed against Telix Pharmaceuticals Ltd. (NASDAQ: TLX) ("Telix" or the "Company") on behalf of investors who purchased Telix securities during the period of February 21, 2025 through August 28, 2025 (the "Class Period"). Investor Deadline: Investors who purchased Telix securities during the Class Period may, no later than January 9, 2026, seek to be appointed as a le ...

Dec 2, 2025 12:23 PM Eastern Standard Time SFM Investors Have Opportunity to Lead Sprouts Farmers Market, Inc. Securities Fraud Lawsuit with the Schall Law Firm Share LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Sprouts Farmers Market, Inc. ("Sprouts†or "the Company†) (NASDAQ: SFM) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U. ...

Core Viewpoint - A class action securities lawsuit has been filed against Perrigo Company plc, alleging securities fraud that affected investors between February 27, 2023, and November 4, 2025 [2][3]. Group 1: Lawsuit Details - The lawsuit claims that Perrigo made false statements and concealed significant issues regarding its infant formula business acquired from Nestlé, including underinvestment in maintenance and operational improvements [3]. - It is alleged that Perrigo needed to incur substantial capital and operational expenditures beyond previously stated estimates to address deficiencies in the infant formula business [3]. - The complaint highlights significant manufacturing deficiencies in the facility related to the infant formula business, leading to overstated financial results, including earnings and cash flow [3]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until January 16, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, indicating no financial obligation to participate [4]. Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [5]. - The firm is recognized as one of the top securities litigation firms in the United States, ranking in ISS Securities Class Action Services' Top 50 Report for seven consecutive years [5].

Core Viewpoint - A class action securities lawsuit has been filed against Baxter International, Inc. due to alleged securities fraud affecting investors between February 23, 2022, and July 30, 2025 [2][3]. Group 1: Lawsuit Details - The lawsuit claims that Baxter's product, the Novum LVP, had systemic defects leading to malfunctions such as underinfusion, overinfusion, and non-delivery of fluids, posing serious risks to patients [3]. - It is alleged that Baxter was aware of multiple malfunctions, injuries, and deaths related to these defects but failed to take adequate remedial measures [3]. - The complaint states that Baxter's public statements regarding the safety, efficacy, and sales prospects of the Novum LVP were materially false and misleading [3]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until December 15, 2025, to request appointment as lead plaintiff, although participation does not require serving in this role [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [5].

Core Viewpoint - A class action securities lawsuit has been filed against Inspire Medical Systems, Inc. due to alleged securities fraud affecting investors between August 6, 2024, and August 4, 2025 [2][3]. Group 1: Lawsuit Details - The lawsuit claims that the launch of Inspire Medical Systems' new product, Inspire V, was unsuccessful due to poor demand and excess inventory at treatment centers, contradicting the company's assurances of a successful launch [3]. - Allegations include that the company failed to complete essential tasks for the product launch, such as training for treatment center customers, setting up IT systems, and ensuring proper Medicare reimbursement [3]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until January 5, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require this [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Group 3: Legal Representation - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the U.S. [5].

Accessibility StatementSkip Navigation KMX investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) defendants recklessly overstated CarMax's growth prospects when, in reality, its earlier growth in the 2026 fiscal year was a temporary benefit from customers buying cars due to speculation regarding tariffs; and (2) as a result, defendants' st ...

Accessibility StatementSkip Navigation NEW YORK, Dec. 2, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Jayud Global Logistics Ltd. ("Jayud Global Logistics Ltd." or the "Company") (NASDAQ: JYD) of a class action securities lawsuit. 21% more press release views with Request a Demo WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm h ...

Core Viewpoint - The StubHub class action lawsuit alleges that the company's IPO documents were misleading, leading to significant financial losses for investors following the announcement of poor financial results [3][4]. Group 1: Class Action Lawsuit Details - The lawsuit, titled Salabaj v. StubHub Holdings, Inc., was filed against StubHub and its executives for violations of the Securities Act of 1933 [1]. - Investors who purchased StubHub common stock during its IPO on September 17, 2025, have until January 23, 2026, to seek appointment as lead plaintiff [1][5]. - StubHub's IPO involved the issuance of approximately 34 million shares at an offering price of $23.50 per share [2]. Group 2: Financial Performance and Allegations - The lawsuit claims that StubHub's offering documents omitted critical information regarding changes in payment timing to vendors, which adversely affected free cash flow [3]. - StubHub reported a free cash flow of negative $4.6 million for Q3 2025, marking a 143% decrease year-over-year, and a 69.3% decrease in net cash provided by operating activities [3]. - Following the release of these financial results, StubHub's stock price fell nearly 21%, and by the time the lawsuit commenced, the stock was trading at $10.31 per share, a decline of nearly 56% from the IPO price [3][4]. Group 3: Legal Representation - Robbins Geller Rudman & Dowd LLP is representing investors in the StubHub class action lawsuit and is recognized as a leading firm in securities fraud litigation [6]. - The firm has a strong track record, having recovered over $2.5 billion for investors in 2024 alone [6].